News | April 17, 2007

Siemens' 350th 3T MagnetomTrio MRI Installed

April 18, 2007 - Siemens Medical Solutions recently installed its 350th 3T MAGNETOM Trio magnetic resonance imaging (MRI) scanner at South Jersey Radiology Associates P.A. of Voorhees, NJ.

With this installation, the high-field imaging system is demonstrating that it is not only a research tool, but that it can also make an impact in clinical imaging. Additionally, the scanner is one of more than 175 worldwide 3T systems that use Siemens Medical Solutions proprietary Tim (Total imaging matrix) coil architecture, which eliminates the need for patient repositioning and manual coil changes during scans while significantly enhancing image quality.

“The Trio will allow us to advance to the next level by imaging those regions that are still problematic at 1.5T: small joints such as the wrist, forefoot and fingers,” said William F. Muhr, Jr., MD, a radiologist at South Jersey Radiology Associates P.A. “The 3T field strength moves our neuroimaging to the next level with diffusion tensor imaging and fiber tracking. The magnet will also benefit patients with renal impairments who cannot tolerate as much gadolinium contrast. The increased signal-to-noise ratio at 3T allows us to perform body imaging and MRA at reduced contrast doses. While performing these applications, the MAGNETOM Trio also excels at routine knee, hip, spine and brain imaging, allowing us to run a full patient schedule right out of the gate.”

The MAGNETOM Trio meets a wide range of imaging needs, from routine clinical use, to high-end research, combining the system’s fast gradients with one of the largest field-of-view acquisitions and the highest 3T magnet homogeneity. Siemens’ Tim technology enables the MAGNETOM Trio to address challenges encountered with other 3T systems, without compromising image quality. The high signal-to-noise ratio of the MAGNETOM Trio, in combination with Tim technology, enables reduced scan times, which consequently reduces motion artifacts, improves patient comfort and helps increase patient throughput.

“The success of MAGNETOM Trio can be attributed to its excellent performance in all radiological settings, from neurology and orthopedics to angiography and abdominal imaging,” said Nancy Gillen, vice president, MR division, Siemens Medical Solutions. “The Trio has brought advanced 3T MRI to not only leading academic medical centers but to diagnostic imaging centers and smaller hospitals as well. And our patented Tim technology continues to yield innovations as exemplified by the new generation of Siemens MRI systems.”

Related Content

Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy
News | Women's Health | August 20, 2019
A small but concerning number of women are exposed to a commonly used magnetic resonance imaging (MRI) contrast agent...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...
Bracco Receives FDA Approval for Varibar Thin Liquid for Oral Suspension
Technology | Contrast Media | August 05, 2019
Bracco Diagnostics Inc. announced U.S. Food and Drug Administration (FDA) approval for Varibar Thin Liquid (barium...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
ITN Wins Jesse H. Neal Award for Best Technical Content
News | Radiology Business | April 24, 2019
April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H.
Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis
One of the most controversial issues in radiology in recent years has been the use of...
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...
Ultrasound Societies Urge FDA to Remove "Black Box" on Ultrasound Contrast Agents
News | Ultrasound Imaging | March 07, 2019
National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black...
Sponsored Content | Case Study | Contrast Media | January 30, 2019
The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of bodil